Persperity Health Secures $1M for Innovative Sweat-Sensing Wearable
Persperity Health, an innovative start-up, has recently announced the successful completion of a $1 million pre-seed funding round. The company is developing a revolutionary wearable device that utilizes non-invasive sweat analysis to monitor hormone levels in women, addressing a crucial gap in the fertility and menopause management space.
The start-up’s patented ring-like biosensor, developed in collaboration with Dr. Wei Gao from Caltech, is equipped with cutting-edge sweat-sensing technology. This innovative approach allows users to easily measure hormones such as estradiol, progesterone, and luteinizing hormone (LH) without the need for arduous workouts or blood-based tests.
Persperity Health’s solution harnesses the power of iontophoresis, a non-invasive process that stimulates sweat production on demand. This method enables users to conveniently track their hormone levels, providing invaluable insights into early signs of hormonal imbalance, ovulation patterns, and menopause symptom management.
“This funding will be instrumental in accelerating our product development and bringing our transformative technology to the market,” said the Persperity Health team. The start-up’s impressive list of investors includes FreeFlow, Wilson Hill, Caltech, Alma Capital, and Merkin Family Office, highlighting the industry’s confidence in their innovative approach.
With this new funding, Persperity Health is poised to revolutionize the way women manage their fertility and menopause, empowering them with real-time, accurate information about their hormonal health. While the exact launch timeline for the first consumer product remains unclear, the company’s commitment to innovation and improving women’s well-being is unquestionable.
